| scholarly article | Q13442814 |
| P2093 | author name string | Iqbal K | |
| Grundke-Iqbal I | |||
| Bancher C | |||
| Zaidi T | |||
| P2860 | cites work | A protein factor essential for microtubule assembly | Q22010837 |
| Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 | ||
| Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology | Q29617284 | ||
| Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin | Q34243042 | ||
| Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly | Q34275737 | ||
| Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease | Q34293057 | ||
| Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. | Q34317415 | ||
| Microtubule Assembly in the Absence of Added Nucleotides | Q35098486 | ||
| Tau protein function in living cells | Q36216609 | ||
| Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis | Q36472868 | ||
| Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition | Q38582618 | ||
| Alzheimer paired helical filaments: immunochemical identification of polypeptides | Q38583308 | ||
| Defective brain microtubule assembly in Alzheimer's disease | Q41893869 | ||
| The primary structure and heterogeneity of tau protein from mouse brain | Q48122949 | ||
| Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. | Q52217665 | ||
| About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. | Q52248369 | ||
| A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. | Q53296439 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 104-108 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation | |
| P478 | volume | 349 |
| Q43828064 | A pool of beta-tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain |
| Q28215096 | Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 |
| Q35911885 | Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau |
| Q52210065 | Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. |
| Q35538854 | Alzheimer Neurofibrillary Degeneration: Therapeutic Targets and High-Throughput Assays |
| Q74222937 | Alzheimer disease |
| Q35114797 | Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention |
| Q52200995 | Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. |
| Q34974083 | Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial |
| Q37184755 | Amyloidogenesis of natively unfolded proteins |
| Q53316981 | Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. |
| Q34473854 | Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. |
| Q53761895 | Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205. |
| Q28255422 | Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau |
| Q37238256 | Cytosolic abnormally hyperphosphorylated tau but not paired helical filaments sequester normal MAPs and inhibit microtubule assembly |
| Q33720139 | Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function. |
| Q52209534 | Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. |
| Q36494716 | Deregulated Cdk5 activity is involved in inducing Alzheimer's disease |
| Q35114786 | Developing pharmacological therapies for Alzheimer disease |
| Q35016882 | Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target |
| Q44270704 | Effect of propionic and methylmalonic acids on the high molecular weight neurofilament subunit (NF-H) in rat cerebral cortex |
| Q47728493 | Effects of acute and chronic administration of methylmalonic and propionic acids on the in vitro incorporation of 32P into cytoskeletal proteins from cerebral cortex of young rats |
| Q42513135 | Effects of methylmalonic and propionic acids on glutamate uptake by synaptosomes and synaptic vesicles and on glutamate release by synaptosomes from cerebral cortex of rats |
| Q34402143 | Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease. |
| Q42689688 | Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease |
| Q28208444 | Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta |
| Q33859830 | Mechanisms of tau-induced neurodegeneration |
| Q73455082 | Methylmalonic and propionic acids increase the in vitro incorporation of 32P into cytoskeletal proteins from cerebral cortex of young rats through NMDA glutamate receptors |
| Q49017516 | Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau. |
| Q53842029 | Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5. |
| Q34610487 | Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease |
| Q40983045 | Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention |
| Q50513992 | Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue binding phosphatases. |
| Q47689049 | Muscarinic therapies in Alzheimer's disease; from palliative treatments to disease modification |
| Q44836303 | Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice |
| Q35224677 | Oxidative stress in neurodegeneration |
| Q48033282 | PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8. |
| Q35058484 | PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo |
| Q49118208 | Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules |
| Q52210052 | Phosphorylation and accumulation of tau without any concomitant increase in tubulin levels in Chinese hamster ovary cells stably transfected with human tau441. |
| Q57186787 | Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat |
| Q44627791 | Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies |
| Q39307688 | Prion-like Spreading in Tauopathies |
| Q42504485 | Regulation of phosphorylation of tau by protein kinases in rat brain |
| Q34785749 | Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease |
| Q45711453 | Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease |
| Q48360366 | Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK. |
| Q34814821 | Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion |
| Q38331253 | Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity |
| Q33926242 | Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice |
| Q27004724 | Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem |
| Q37744878 | Targeting tau protein in Alzheimer's disease |
| Q38658752 | Tau and neurodegenerative disease: the story so far. |
| Q24312948 | Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis |
| Q34953869 | Tau in Alzheimer disease and related tauopathies |
| Q28285346 | Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase |
| Q33793293 | Tau pathology generated by overexpression of tau. |
| Q22252520 | Tau pathology in Alzheimer disease and other tauopathies |
| Q35712546 | The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells |
| Q22010198 | The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein |
| Q35264520 | Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies. |
Search more.